AAAAAA

   
Results: 1-10 |
Results: 10
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation
Authors: Flynn, AA Pedley, RB Green, AJ Boxer, GM Boden, R Dearling, J Bhatia, J Begent, RHJ
Citation: Aa. Flynn et al., Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation, INT J RAD B, 77(4), 2001, pp. 507-517
Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images
Authors: Flynn, AA Boxer, GM Begent, RHJ Pedley, RB
Citation: Aa. Flynn et al., Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images, CANCER IMMU, 50(2), 2001, pp. 77-81
A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor
Authors: Flynn, AA Green, AJ Pedley, RB Boxer, GM Boden, R Begent, RHJ
Citation: Aa. Flynn et al., A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor, RADIAT RES, 156(1), 2001, pp. 28-35
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate
Authors: Pedley, RB Hill, SA Boxer, GM Flynn, AA Boden, R Watson, R Dearling, J Chaplin, DJ Begent, RHJ
Citation: Rb. Pedley et al., Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate, CANCER RES, 61(12), 2001, pp. 4716-4722
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody
Authors: Mayer, A Tsiompanou, E O'Malley, D Boxer, GM Bhatia, J Flynn, AA Chester, KA Davidson, BR Lewis, AAM Winslet, MC Dhillon, AP Hilson, AJW Begent, RHJ
Citation: A. Mayer et al., Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody, CLIN CANC R, 6(5), 2000, pp. 1711-1719
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer
Authors: Chester, KA Mayer, A Bhatia, J Robson, L Spencer, DIR Cooke, SP Flynn, AA Sharma, SK Boxer, G Pedley, RB Begent, RHJ
Citation: Ka. Chester et al., Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer, CANC CHEMOT, 46, 2000, pp. S8-S12
Clinical applications of phage-derived sFvs and sFv fusion proteins
Authors: Chester, KA Bhatia, J Boxer, G Cooke, SP Flynn, AA Huhalov, A Mayer, A Pedley, RB Robson, L Sharma, SK Spencer, DIR Begent, RHJ
Citation: Ka. Chester et al., Clinical applications of phage-derived sFvs and sFv fusion proteins, DIS MARKER, 16(1-2), 2000, pp. 53-62
A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel
Authors: Flynn, AA Green, AJ Boxer, GM Casey, JL Pedley, RB Begent, RHJ
Citation: Aa. Flynn et al., A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel, INT J RAD O, 43(1), 1999, pp. 183-189
A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology
Authors: Flynn, AA Green, AJ Boxer, G Pedley, RB Begent, RHJ
Citation: Aa. Flynn et al., A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology, PHYS MED BI, 44(7), 1999, pp. N151-N159
Taking engineered anti-CEA antibodies to the clinic
Authors: Mayer, A Chester, KA Flynn, AA Begent, RHJ
Citation: A. Mayer et al., Taking engineered anti-CEA antibodies to the clinic, J IMMUNOL M, 231(1-2), 1999, pp. 261-273
Risultati: 1-10 |